Dispense As Written Prescription Instructions and Their Impact on Plan Sponsors and Participants by Joe Schmidt, MBA, Vice President | Team Lead Before the
Common Sense Management of Narcolepsy and Cataplexy by Bob Kordella, R.Ph., MBA, Chief Clinical
November 30, 2020:Where We Are Today And When Will New Vaccines Be Approved? by
COVID-19 Vaccine Update by Bob Kordella, R.Ph., MBA, Chief Clinical Officer As several COVID-19
The Rebate Bubble by Jonalan Smith, PharmD, FASCP, Senior Vice President Everyone knows the
The Impact Of Humira Citrate-Free by Bob Kordella, R.Ph., MBA Humira is typically in
HIV PrEP Therapies by Darian Hurst, Vice President In June 2019, the United States
Specialty Drug Manufacturer Assistance Programs And Your Plan by Sarah Martin, ASA, MAAA, FCA,
Psychosocial Barriers Affecting Medication Adherence; the Importance of the Provider/Patient Relationship by Clay Keene, Vice
What is the Purpose of the Drug Watch List? by Bob Kordella, RPh, MBA,
© Copyright 2019 Excelsior Solutions • Privacy Policy • All Rights Reserved